European equities clawed back ground on Friday as merger activity in the pharmaceutical sector provided support while investors digested data showing a further rise of unemployment in the eurozone
Jan 30
Japanese shares dropped as even bleaker-than-expected data shook sentiment and the onslaught on grim earnings weighed on the market
Jan 30
Last year’s sell-off was so severe across all asset classes that some will now almost certainly begin to outperform, says John Authers
